You have no items in your shopping cart.
Cinanserin hydrochloride
SKU: orb1308451
Description
Research Area
Infectious Disease & Virology, Neuroscience, Pharmacology & Drug Discovery
Images & Validation
−
Key Properties
−| CAS Number | 54-84-2 |
|---|---|
| MW | 376.94 |
| Purity | 99.32% |
| Formula | C20H25ClN2OS |
| SMILES | Cl.CN(C)CCCSc1ccccc1NC(=O)C=Cc1ccccc1 |
| Target | 5-HT Receptor,Influenza Virus |
| Solubility | H2O:100 mg/mL (265.29 mM);DMSO:125 mg/mL (331.62 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.61 mM) |
Bioactivity
−| Target IC50 | |
|---|---|
| In Vivo | |
| In Vitro |
Storage & Handling
−| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−5-HT2, 5-HT2 Receptor, 5-HT Receptor, 5HT Receptor, 5-hydroxytryptamine Receptor, 5HTReceptor, 3C-like, 3C-like proteinase, burn, Cinanserin, Cinanserin hydrochloride, Cinanserin Hydrochloride, Influenza Virus, InfluenzaVirus, inhibit, edema, endothelial, leukocyte, Inhibitor, proteinase, replication, SQ 10643, SQ10643, SQ-10643, systemic, Serotonin Receptor, virus

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
Cinanserin hydrochloride (orb1308451)
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review